a case report from China describing synergistic effect of convalescence plasma and Msc
The patient continued to deteriorate even after administration of antiviral drugs such as lopinavir/ritonavir, interferon-α, and ribavirin, as well as intravenous injection of meropenem, methylprednisolone, and immunoglobulin. So, we infused the patient with convalescent plasma (CP), and the absolute lymphocyte count increased the next day and returned to normal on the fourth day. Followed by intravenous infusion of mesenchymal stem cells (MSCs), bilateral infiltrates were absorbed and the pulmonary function was significantly improved. We note that the intravenous infusion of CP and MSCs for the treatment of severe COVID-19 patients may have synergistic characteristics in inhibiting cytokine storm, promoting the repair of lung injury, and recovering pulmonary function. We hope to provide a reference for the research direction of COVID-19 clinical strategies.
https://pubmed.ncbi.nlm.nih.gov/32678017/ce
Authors declared no conflict of interest.
- Forums
- ASX - By Stock
- Ann: Ethics Approval to Commence Clinical Trial in COVID-19
a case report from China describing synergistic effect of...
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.21M |
Open | High | Low | Value | Volume |
22.5¢ | 23.5¢ | 22.0¢ | $14.22K | 63.24K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30215 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 20393 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30215 | 0.220 |
1 | 86380 | 0.210 |
3 | 100257 | 0.200 |
2 | 13135 | 0.195 |
1 | 30000 | 0.190 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 20393 | 2 |
0.240 | 91350 | 1 |
0.245 | 10000 | 1 |
0.250 | 42019 | 2 |
0.275 | 21895 | 1 |
Last trade - 14.56pm 08/05/2024 (20 minute delay) ? |
|
|||||
Last
22.5¢ |
  |
Change
0.000 ( 4.26 %) |
|||
Open | High | Low | Volume | ||
23.0¢ | 23.0¢ | 22.5¢ | 2600 | ||
Last updated 14.34pm 08/05/2024 ? |
Featured News
CYP (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online